Author: Bella Hayes
New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) pursuant and/or traceable to the Kyverna’s initial public offering conducted on February 8, 2024 (the “IPO”), of the important February 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased Kyverna common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Kyverna class action, go to https://rosenlegal.com/submit-form/?case_id=32239 or call…
New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zeta Global (NYSE:) Holdings Corp. (NYSE: ZETA) between February 27, 2024 and November 13, 2024, both dates inclusive (the “Class Period”), of the important January 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Zeta securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Zeta class action, go to https://rosenlegal.com/submit-form/?case_id=31333…
New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marqeta , Inc. (NASDAQ: NASDAQ:) between May 7, 2024 and November 4, 2024, both dates inclusive (the “Class Period”), of the important February 7, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Marqeta securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join…
New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MGP Ingredients , Inc. (NASDAQ: NASDAQ:) between May 4, 2023 and October 30, 2024, of the important February 14, 2025 lead plaintiff deadline. SO WHAT: If you purchased MGPI common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the MGPI class action, go to https://rosenlegal.com/submit-form/?case_id=9167 or call Phillip Kim, Esq.…
New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Kaspi.kz securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To…
Philadelphia, Pennsylvania–(Newsfile Corp. – December 29, 2024) – Grabar Law Office is investigating whether certain officers and directors of Expensify , Inc. (NASDAQ: NASDAQ:) breached their fiduciary duties owed toward the company. Current Expensify shareholders who have held shares of Expensify stock since on or near its November 11, 2021 IPO, can seek corporate reforms, the return of funds back to company coffers, and potentially receive a court approved incentive award. You are encouraged to visit https://grabarlaw.com/the-latest/expensify-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085. Why: On October 15, 2021, Expensify filed a registration statement on Form S-1…
New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Match Group, Inc. (NASDAQ: NASDAQ:) between May 2, 2023 and November 6, 2024, both dates inclusive (the “Class Period”), of the important January 24, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Match Group securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To…
New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Warner Bros. Discovery, Inc. (NASDAQ: NASDAQ:) between February 23, 2024 and August 7, 2024, both dates inclusive (the “Class Period”), of the important January 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased WBD securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the WBD class action, go to https://rosenlegal.com/submit-form/?case_id=31683 or…
New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS”) of Rentokil Initial plc (NYSE: LON:) between December 1, 2023 and September 10, 2024, both dates inclusive (the “Class Period”), of the important January 27, 2025 lead plaintiff deadline. SO WHAT: If you purchased Rentokil ADSs during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Rentokil class action, go to…
New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: NASDAQ:) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Applied Therapeutics class action, go to https://rosenlegal.com/submit-form/?case_id=32500 or…